For over 24 years Dr O’Reilly has worked as Consultant Rheumatologist at the West Suffolk Hospital. For ten of those years he worked as a Physician in emergency medicine.
In 2016 the British Society for Rheumatology made him a 'Distinguished Member' for service to the specialty.
He specialises in the early diagnosis and treatment of inflammation based arthritis; for instance rheumatoid, psoriatic and reactive arthritis. With appropriate conventional treatment tailored specifically to the individual the majority of patients will have well controlled disease with much reduced risk of long term problems. For patients with difficult disease he has over 15 years' experience in the use of the 'biological' treatments for arthritis conditions. The cost of these drugs has halved recently but their NHS use is still restricted. Some patients are paying for these drugs themselves to improve their condition.
He also manages the full range of musculoskeletal and inflammatory disorders such as back pain, neck pain, osteoporosis and polymyalgia etc on a daily basis.
In Rheumatology good results require a close working relationship between specialist and patient. To see how seriously he takes this relationship see feedback from patients and colleagues on the "Reviews" page at RheumatologyUK.com and iwantgreatcare.org
Dr O'Reilly is able to assist patients with the following:
Muscle and soft tissue pain
Giant Cell Arteritis
Biologic treatments for arthritis (Humira, Benepali)
Lupus / SLE
Treatments and tests offered by Dr David O’Reilly at Nuffield Health
- Rheumatology profiles
- Osteoporosis screen
- Contemporary treatment principles for early rheumatoid arthritis: a consensus statement.P Kiely, A Brown, C Edwards, D O’Reilly, A Östör, M Quinn, A Taggart, P Taylor, R Wakeﬁeld, and P Conaghan Rheumatology, July 2009; 48: 765 – 772
- Tolerability of methotrexate and leflunomide combination therapy for inflammatory arthritis in routine clinical practice: results of a four-centre study. A Kaul, D O’Reilly, R Slack, D.Collins, J Walmsley, O Duke and P Kiely Rheumatology, September 2008; 47: 1430 – 1431
- Imatinib Treatment of Seropositive Arthritis in a Young Woman with Chronic Myeloid Leukemia. P Ames, W Aye, C Beatty, and D O’Reilly J Rheumatol August 2008 35(8):1682
- Quantification of cold challenge responses in primary Raynaud’s phenomenon and systemic sclerosis associated Raynaud’s phenomenon. D O’Reilly, L Lyon, K el Hadidi and MIV Jayson. Ref: Annals Rheumatic Diseases 1992; 51: page nos. 1193 to 1196
- Sustained-Release Transdermal Glyceryl Trinitrate patches as a treatment for primary and secondary Raynaud’s Phenomenon. L.S. Teh, J. Manning, T. Moore, M.P. Tully, D O’Reilly, M.I.V. Jason. British Journal of Rheumatology 1995;34: 636 – 641
- Carcinoma of the colon presenting with dyspepsia. D O’Reilly, RG Long. Postgraduate Medical Journal 1987; 63: 215-216.
- British Society for Rheumatology (Distinguished member 2016)
- Fellow of Royal College of Physicians
- National Rheumatoid Arthritis Society
- National Osteoporosis Society
- Medical Defence Union
Other post held
- West Suffolk Hospital
Insurers Dr David O’Reilly works with
Dr David O’Reilly works with the following private medical insurance providers:
- Aviva Health
- AXA PPP Healthcare
- AXA PPP International
- Benenden Health
- CS Healthcare
- Exeter Family Friendly
- Vitality Health (Pru Health)
- Westfield Health WPA
Dr David O’Reilly does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.
Dr David O’Reilly does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.
Dr David O’Reilly does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.